<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02290093</url>
  </required_header>
  <id_info>
    <org_study_id>4LPEG-2LPEGA-Elderly-2014</org_study_id>
    <nct_id>NCT02290093</nct_id>
  </id_info>
  <brief_title>Bowel Preparation for Colonoscopy in the Elderly</brief_title>
  <official_title>Bowel Preparation With Standard 4 Liters of PEG vs. Split-dose of 4 Liters PEG vs. Split-dose of 2 Liters PEG Containing Ascorbic Acid Solutions for Outpatient Elective Colonoscopy in the Elderly: A Randomized, Colonoscopist-blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyunghee University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kangbuk Samsung Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanyang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kyunghee University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The success of colonoscopy is closely related to the quality of colonic preparation. However,
      data regarding colonoscopy preparations in the elderly (65 years older) are scarce.
      Split-dosage cathartic bowel preparation are currently suggested, whereas supporting evidence
      is lacking in this particular group of patients. Moreover, patient tolerability is a key
      factor for success of bowel preparation in the aged people.

      The purpose of this study is to compare the bowel cleansing efficacy and patient compliance
      of following bowel preparation methods prior to elective outpatient colonoscopy in the
      elderly: (1) standard preparation of 4 liters (L) PEG-3350 solution on the night before
      colonoscopy, (2) split-dose of 4L PEG-3350 solution, and (3) split-dose of reduced volume
      [2L] PEG-3350 containing ascorbic acid solution.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of adequate bowel preparation quality at the time of colonoscopy defined by the Boston bowel preparation scale (BBPS).</measure>
    <time_frame>1 year</time_frame>
    <description>The BBPS assesses cleanliness of 3 segments of the colon (ascending, transverse, and descending colon), and the total is a 10-point scale (0-9) that grades each segment of the colon from 0 to 3. In this study, adequate bowel preparation is defined as a total score 6 points or higher and individual score of 2 points or higher in each segment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with recommended bowel preparation method based on the 10-point visual analog scale</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of adverse events related to bowel preparation for colonoscopy</measure>
    <time_frame>1 year</time_frame>
    <description>Adverse events include tenesmus, sleep disturbance, nausea, vomiting, abdominal cramping, abdominal fullness, abdominal discomfort, headache, dizziness, and others.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who have a willingness to repeat same bowel preparation method method</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumed volume of recommended bowel preparation agent based on the 3-grade scale</measure>
    <time_frame>1 year</time_frame>
    <description>The 3-grade scale: optimal (100%), good (≥ 75%), and poor (&lt; 75%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty of completing ingestion of recommended bowel preparation agent based on the 3-grade scale</measure>
    <time_frame>1 year</time_frame>
    <description>The 3-grade scale: never, some, and much</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Taste of recommended bowel preparation agent based on the 3-grade scale</measure>
    <time_frame>1 year</time_frame>
    <description>The 3-grade scale: bad, neutral, and good</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">230</enrollment>
  <condition>Bowel Preparation</condition>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Standard full-volume PEG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Split-dose full-volume PEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Split-dose low-volume PEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard full-volume PEG</intervention_name>
    <description>Subjects will be asked to take 4L of PEG-3350 solution the day prior to procedure.</description>
    <arm_group_label>Standard full-volume PEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Split-dose full-volume PEG</intervention_name>
    <description>Subjects will be asked to take 2L of PEG-3350 solution the day prior to procedure, followed by another 2L of PEG-3350 solution on the day of the procedure.</description>
    <arm_group_label>Split-dose full-volume PEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Split-dose low-volume PEG</intervention_name>
    <description>Subjects will be asked to take 1L of PEG-3350 containing ascorbic acid solution the day prior to procedure, followed by another 1L of PEG-3350 containing ascorbic acid solution on the day of the procedure.</description>
    <arm_group_label>Split-dose low-volume PEG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elderly people aged over 65 years

          -  elective outpatient colonoscopy

          -  informed consent

        Exclusion Criteria:

          -  patients who had bowel movements of less than 3 per week during last one month

          -  patients who have a history of renal dysfunction (abnormal elevation of serum
             creatinine and electrolyte imbalance)

          -  patients who have a history of alimentary tract surgery

          -  patients who have other gastrointestinal diseases that are not suitable for undergoing
             colonoscopy (gastroparesis, gastric outlet obstruction, ileus, ischemic colitis,
             megacolon, and toxic colitis)

          -  patients classified as the American Society for Anesthesiology class III or higher

          -  Any condition which, in the opinion of the Investigator, places the patient at
             unacceptable risk if he/she were to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hanyang University Guri Hospital</name>
      <address>
        <city>Guri</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-746</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyung Hee University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>130-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Cohen LB. Split dosing of bowel preparations for colonoscopy: an analysis of its efficacy, safety, and tolerability. Gastrointest Endosc. 2010 Aug;72(2):406-12. doi: 10.1016/j.gie.2010.04.001. Epub 2010 Jul 1. Review.</citation>
    <PMID>20579994</PMID>
  </reference>
  <reference>
    <citation>ASGE Standards of Practice Committee, Chandrasekhara V, Early DS, Acosta RD, Chathadi KV, Decker GA, Evans JA, Fanelli RD, Fisher DA, Foley KQ, Fonkalsrud L, Hwang JH, Jue T, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Shergill AK, Cash BD. Modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2013 Jul;78(1):1-7. doi: 10.1016/j.gie.2013.04.161. Epub 2013 May 9. Review. Erratum in: Gastrointest Endosc. 2013 Sep;78(3):559.</citation>
    <PMID>23664042</PMID>
  </reference>
  <results_reference>
    <citation>Ell C, Fischbach W, Bronisch HJ, Dertinger S, Layer P, Rünzi M, Schneider T, Kachel G, Grüger J, Köllinger M, Nagell W, Goerg KJ, Wanitschke R, Gruss HJ. Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy. Am J Gastroenterol. 2008 Apr;103(4):883-93. doi: 10.1111/j.1572-0241.2007.01708.x. Epub 2008 Jan 11.</citation>
    <PMID>18190651</PMID>
  </results_reference>
  <results_reference>
    <citation>Téllez-Ávila FI, Murcio-Pérez E, Saúl A, Herrera-Gómez S, Valdovinos-Andraca F, Acosta-Nava V, Barreto R, Elizondo-Rivera J. Efficacy and tolerability of low-volume (2 L) versus single- (4 L) versus split-dose (2 L + 2 L) polyethylene glycol bowel preparation for colonoscopy: randomized clinical trial. Dig Endosc. 2014 Nov;26(6):731-6. doi: 10.1111/den.12265. Epub 2014 Mar 20.</citation>
    <PMID>24645966</PMID>
  </results_reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2014</study_first_submitted>
  <study_first_submitted_qc>November 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2014</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyunghee University Medical Center</investigator_affiliation>
    <investigator_full_name>Chang Kyun Lee</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Cathartics</keyword>
  <keyword>Colonoscopy</keyword>
  <keyword>Polyethylene Glycols</keyword>
  <keyword>Elderly</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

